Skip to content

OnKure Therapeutics, Inc. OKUR Other Liabilities Assumed In Connection With The Reverse Recapitalization

Other Liabilities Assumed In Connection With The Reverse Recapitalization at other companies

DTC
Datacentrex, Inc. DTCX
-$31.9K
TuHURA Biosciences, Inc. logo
TuHURA Biosciences, Inc.HURA
$137.5K
TuHURA Biosciences, Inc. logo
TuHURA Biosciences, Inc.HURA
$550K+176%
Construction Partners logo
Construction PartnersROAD
$0
Covenant Logistics Group logo
Covenant Logistics GroupCVLG
-$208.75K-4.4%
XCF Global, Inc. Class A Common Stock logo
XCF Global, Inc. Class A Common StockSAFX
-$93.65M

Other financials

Income statement

See full
Revenue-
Operating income-$15.6M+8.1%
Net income-$15.2M+4.8%
EPS (diluted)-$1.11+6.7%

Balance sheet

See full
Cash & equivalents$192.1M+98.7%
Total debt$409.0K-57.2%
Total equity$184.4M+103%
Total assets$198.7M+98.9%

Cash flow

See full
Operating cash flow-$12.9M+7.6%
CapEx$5.0K-72.2%
Free cash flow-$12.9M+7.7%

Valuation

See full
Market cap$184.2M+72.6%
Enterprise value-$7.49M-127%

Returns & leverage

See full
Return on equity-42.7%
Debt / equity0.0×
Current ratio13.8×+2.6×

Where this comes from

Reported directly by OnKure Therapeutics, Inc. in its filing.

Tagged under the XBRL concept okur:OtherLiabilitiesAssumedInConnectionWithTheReverseRecapitalization.

The official record: OnKure Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about OnKure Therapeutics, Inc.'s other liabilities assumed in connection with the reverse recapitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OnKure Therapeutics, Inc.'s other liabilities assumed in connection with the reverse recapitalization?
OnKure Therapeutics, Inc. (OKUR) reported other liabilities assumed in connection with the reverse recapitalization of $2.36M in Q4 2024.
What does other liabilities assumed in connection with the reverse recapitalization mean?
The value of liabilities inherited or assumed by the company as part of a reverse recapitalization transaction. Tracking these obligations is essential for understanding the net impact of the transaction on the company's long-term debt profile.